Clincosm LogoSign in Get a demo

ali

Showing 1 - 4 of 4
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

SARS-CoV 2, COVID, ARDS Trial in United States (ZYESAMI™ (aviptadil acetate), Placebo, Nebulized administration of ZYESAMI™ or

Terminated
  • SARS-CoV 2
  • +5 more
  • ZYESAMI™ (aviptadil acetate)
  • +2 more
  • Fullerton, California
  • +12 more
Feb 2, 2023

SARS-CoV 2, COVID, ARDS Trial (ZYESAMI™ (aviptadil acetate), Placebo, Nebulized administration of ZYESAMI™ or Placebo)

Withdrawn
  • SARS-CoV 2
  • +5 more
  • ZYESAMI™ (aviptadil acetate)
  • +2 more
  • (no location specified)
Feb 2, 2023

Covid19, ARDS, Human, ALI Trial in Lund

Recruiting
  • Covid19
  • +2 more
    • Lund, Skåne Län, Sweden
      Region Skåne
    Apr 4, 2022

    Acute Lung Injury, ALI, COVID-19 Trial in Detroit (RLS-0071 10 mg/kg, RLS-0071 40 mg/kg, Placebo)

    Withdrawn
    • Acute Lung Injury
    • +2 more
    • RLS-0071 10 mg/kg
    • +2 more
    • Detroit, Michigan
      Henry Ford Health Systems
    Jan 20, 2022